Table 2 PET/CT and laboratory findings
PET/CT and laboratory findings | No. of patients | % |
|---|---|---|
Metastases | 87 | 81.3 |
18F-FDG avid metastases quantifiable by PET/CT | 76 | 71.0 |
Whole body metabolic tumor volume (MTV, cm3) | 48.6 | |
Median | 2.74 | |
Interquartile range (25–75) | 0.30–9.22 | |
Whole-body total lesion glycolysis (TLG) | ||
Median | 13.0 | |
Interquartile range (25–75) | 1.17–64.30 | |
SUVpeak | ||
Median | 6.7 | |
Interquartile range (25–75) | 2.53–12.60 | |
Serum lactate dehydrogenase (mean: 241 [130–960] U/l) | 84 | 78.5 |
Normal | 64 | 76.2 |
Increased | 18 | 21.4 |
Serum S-100 protein (mean: 0.14 [0.02–3.0] μg/l) | 82 | 76.6 |
Normal | 59 | 72.0 |
Increased | 23 | 28.0 |
C-reactive protein (mean: 3.0 [0.01–16.7] mg/dl) | 72 | 67.3 |
Normal | 28 | 38.9 |
Increased | 44 | 61.1 |
Alkaline phosphatase (mean: 91 [36–175] μg/l) | 68 | 63.6 |
Normal | 56 | 82.4 |
Increased | 12 | 17.6 |